cyclobenzaprine
Vérifier sur tripsit
Cyclobenzaprine
Vérifier sur psychonaut
Cyclobenzaprine
Vérifier sur isomerdesign
Cyclobenzaprine
Vérifier sur pubchem
Cyclobenzaprine
Vérifier sur drugmap
Cyclobenzaprine
Vérifier sur wiki
Data
InChI: InChI=1S/C20H21N/c1-21(2)15-7-12-20-18-10-5-3-8-16(18)13-14-17-9-4-6-11-19(17)20/h3-6,8-14H,7,15H2,1-2H3
Synonymes: 5-(3-dimethylaminopropylidene)-5H-dibenzo[a,d]cycloheptene,5-(3-dimethylaminopropylidene)- 5H-dibenzo[a,d]cycloheptene,Prestwick2_000445,NCGC00013841-19,apo-cyclobenzaprin,NCGC00013841-05,N,N-Dimethyl-5H-dibenzo(a,d)cycloheptene-delta5,gamma-propylamine,BDBM112774,dimethyl({3-[(2E)-tricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-2-ylidene]propyl})amine, 5-(3-Dimetilaminopropiliden)-5H-dibenzo-(a,d)-ciclopentene,MK 130,MK-130 HCl,NCIStruc2_001486,DTXSID0046933,KBioGR_000643,Oprea1_534683,NSC78206,AB00514668,D07758, MK 130,BRD-K42348709-003-05-7,CAS-6202-23-9, Flexeril hydrochloride, Apo-Cyclobenzaprine (TN),(3-Dibenzo[a,d]cyclohepten-5-ylidene-propyl)-dimethyl-amine,ZINC968263,NCGC00013841-08, 3-(5H-dibenzo[a,d][7]annulen-5-ylidene)-N,N-dimethylpropan-1-amine,flexeril,9715 R.P,AKOS025255657,KBio2_004583,303-53-7, 1-Propanamine, 3-(5H-dibenzo(a,d)cyclohepten-5-ylidene)-N,N-dimethyl-(9CI),Prestwick0_000445,N,N-DIMETHYL-5H-DIBENZO(A,D)CYCLOHEPTENE-(SUP .DELTA.5,.GAMMA.)-PROPYLAMINE,10,11-Dehydroamitriptyline,69O5WQQ5TI,CYCLOBENZAPRINE [VANDF],NCGC00013841-03,3-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine, Flexeril (TN), Fexmid,5-(3-Dimetilaminopropiliden)-5H-dibenzo-(a,d)-ciclopentene [Italian],KBio3_002572,5H-Dibenzo(a,d)cycloheptene-.delta.5,.gamma.-propylamine, N,N-dimethyl-,US8629135, SW-01,cyclobenzaprine,novo-cycloprine,Ciclobenzaprina,3-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine,BPBio1_000540,BBL035415,Ro 4-1577, Yurelax,Q5198674,DivK1c_000047, NCI78206,N,N-Dimethyl-5H-dibenzo(a,d)cycloheptene-delta(sup 5),gamma-propylamine,RP 9715,Prestwick3_000445,NCGC00013841,1-Propanamine, 3-(5H-dibenzo(a,d)cyclohepten-5-ylidene)-N,N-dimethyl-,BIDD:GT0485, 9715 R.P., 10,11-Dehydroamitriptyline,BSPBio_003072,Cyclobenzaprine, Proheptatrien, Cyclobenzaprinum [INN-Latin],Spectrum_001535,Spectrum5_001259,L001021, Cyclobenzaprine [INN],CHEMBL669, Proheptatriene,3-(dibenzo[1,2-a:1',2'-e][7]annulen-11-ylidene)-N,N-dimethylpropan-1-amine,Lisseril,MRF-0000742,SDCCGSBI-0050291.P005,BSPBio_000490,NCIStruc1_001572,Flexeril hydrochloride,KBio2_002015,AB00053651_07,MK-130,Proheptatrien,303C537,CHEBI:3996,SPBio_002429,3-(5H-DIBENZO(A,D)(7)ANNULEN-5-YLIDENE)-N,N-DIMETHYLPROPAN-1-AMINE,Fexmid, 5-(3-Dimetilaminopropiliden)-5H-dibenzo-(a,d)-ciclopentene [Italian],Lopac-C-4542,GTPL7152,SPBio_001348, Proeptatriene,Prestwick1_000445,KBioSS_002015,CYCLOBENZAPRINE [MI], Lisseril, Ro 4-1577,HSDB 8305,FT-0603167,SBI-0050291.P003, 9715 R.P,Amrix (Salt/Mix),dimethyl(3-{tricyclo[9.4.0.0,3,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-2-ylidene}propyl)amine,IDI1_000047,UNII-69O5WQQ5TI,N,N-dimethyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)propan-1-amine,NSC173379,BIDD:PXR0152, MK-130 HCl,CYCLOBENZAPRINE [USP IMPURITY], Fexmid(TN),Flexeril (Salt/Mix),NCGC00162122-01,NSC169900,AMITRIPTYLINE HYDROCHLORIDE IMPURITY B [EP IMPURITY],1-Propanamine, 3-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethyl-,Proeptatriene, Cyclobenz,NCI60_041725,KBio1_000047,NORTRIPTYLINE HYDROCHLORIDE IMPURITY E [EP IMPURITY], Proeptatriene [Italian],STL416209,BRD-K42348709-003-08-1,NINDS_000047,Cyclobenzaprine hydrochloride (Salt/Mix),5-(3-Dimetilaminopropiliden)-5H-dibenzo-(a,d)-ciclopentene,TNX-102,Proheptatriene,3-(5H-dibenzo[a,d][7]annulen-5-ylidene)-N,N-dimethylpropan-1-amine,NCGC00013841-04,Spectrum4_000162,Ciclobenzaprina [INN-Spanish],NCI78206, Cyclobenzaprinum,Spectrum2_001534,Cyclobenzaprinum,EINECS 206-145-8,N,N-Dimethyl-3-(dibenzo(a,d)cycloheptene-4-ylidene)propylamine,EN300-708806,Cyclobenzaprine [INN],DB00924,9715 R.P.,Proeptatriene [Italian],NCGC00096951-01,CCG-36511, N,N-Dimethyl-5H-dibenzo(a,d)cycloheptene-delta(sup 5),gamma-propylamine,C06931,NCGC00013841-02, Flexeril, N,N-dimethyl-5H-dibenzo(a,d)cycloheptene-Delta(5,gamma)-propylamine,3-(5H-Dibenzo[a,d]-cyclohepten-5-ylidene)-N,N-dimethylpropylamine,NCGC00013841-06,fexmid, Cyclobenzaprine (INN),Spectrum3_001566,Cyclobenzaprinum [INN-Latin], 3-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine,CYCLOBENZAPRINE [WHO-DD],Cyclobenzaprine (INN),3-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine #, N,N-Dimethyl-3-(dibenzo(a,d)cycloheptene-4-ylidene)propylamine, 3-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine, Amrix (TN),MK-130 (AS THE BASE),Lopac0_000303, Ciclobenzaprina [INN-Spanish],Cycloflex (Salt/Mix),N,N-Dimethyl-5H-dibenzo(a,d)cycloheptene-.delta.5,.gamma.-propylamine,KBio2_007151,5H-DIBENZO(a,d)CYCLOHEPTENE-delta(sup 5),gamma-PROPYLAMINE, N,N-DIMETHYL-,SCHEMBL38527,DB-047767,3-(dibenzo[[?],[?]][7]annulen-11-ylidene)-N,N-dimethyl-propan-1-amine,QTL1_000027,N,N-dimethyl-5H-dibenzo(a,d)cycloheptene-Delta(5,gamma)-propylamine
Estimated data
Solubility: -4.175 (log(S) in mol/L prediction using SolTranNet)
Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)
Addictivity Prediction: 50.2% (prediction based on www.mdpi.com)
